Published on : Jul 21, 2017
Albany, New York, July 21, 2017: Increase in hospital acquired infection, pathogen and microbes infection has impacted the growing demand for GeneFluidics Inc pipeline products. To discuss the detail pipeline product development, Market Research Hub (MRH) has lately added an assessment titled as “GeneFluidics Inc-Product Pipeline Analysis, 2017 Update” to its vast collection. This intelligently analyzed report is a detailed and evaluated source to the company’s pipeline products and provides key information about the company, major products and brands.
GeneFluidics has acquired immense position in the market for providing products for hospital acquired infection (HAI), pathogen identification and antimicrobial susceptibility testing. The HAI are the most common infections that occur in approximately one in every 25 patients. It also provide molecular-based, PCR-less identification of bacterial/viral/fungal and species-specific genes. The targeted company also provides the molecular-based, PCR-less identification of species-specific phenotypic markers of resistance and susceptibility.
GeneFluidics Inc (GeneFluidics) is a molecular analysis service provider, which offers hospital acquired infection, pathogen identification, and antimicrobial susceptibility testing services. The company has various products such as sensor chips, multi-channel reader, robotic automation system, point of care system and systems operation cartridges, among others. The company implies a molecular analysis platform that enables bioassays to perform immunoassays and genetic assays, without the use of purification. It further offers testing system and electrochemical sensor platform for molecular analysis. The major clients of the company include hospitals, healthcare centers, and laboratories in different parts of the United States.
The report initiates with the company overview, its snapshot and pipeline products & ongoing clinical trials overview. It further discusses the GeneFluidics Inc. pipeline analysis overview with the companies key facts, major products & services, pipeline products by development stage and lastly the pipeline products overview. The pipelined products comprise BSI PID/AST centrifluidic system, free T3 assay, free T4 assay, T3 assay and T4 assay. Finally, the study concludes with GeneFluidics Inc. key competitors, key employees, and its locations & subsidiaries. This comprehensive accessed study has enhanced the decision-making capabilities and helps to create effective counter-strategies to gain competitive advantage. The report develops the various business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape for detailed understanding by the strategic partners and investors. The report suspends with the tables and figures that depict the company’s pipeline assessment by-products and their status.
Click here to get more info with TOC in a PDF Format : http://www.marketresearchhub.com/enquiry.php?type=S&repid=1222538
About Market Research Hub
Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.
MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.
For Enquiries, Call :
+1-800-998-4852US Toll Free
Email : firstname.lastname@example.org